Beginner Courses
Foundations, safety, microdosing 101, and first-trip planning for newcomers. Start here if you are new to psilocybin.
Structured learning paths from beginner basics to advanced science and professional programs — built on evidence, grounded in harm reduction
Foundations, safety, microdosing 101, and first-trip planning for newcomers. Start here if you are new to psilocybin.
Research deep-dives, chemistry, neuroscience, therapeutic applications, and integration mastery for experienced learners.
Paths for therapists, integration coaches, researchers, and harm-reduction professionals seeking formal credentials.
Psilobase was built on a single conviction: accurate, evidence-based information reduces harm. The history of psychedelic harm — both physical and psychological — is substantially a history of misinformation. People who understand pharmacology, contraindications, set and setting, and dosing make safer decisions than people who operate on myth, marketing, or incomplete data.
Every page on this site applies the following standards: claims are sourced to peer-reviewed research wherever possible; uncertainty is acknowledged explicitly rather than glossed over; harm-reduction information is presented before anything else; and legal context is never omitted. Where evidence is thin, we say so. This distinguishes evidence-based harm-reduction education from advocacy, entertainment, or promotion.
We do not take a position on whether psilocybin use is wise or unwise for any given individual. We take a position that people who make their own informed decisions deserve accurate information to make those decisions well.
Psilobase is organized as a structured knowledge base, not a random collection of articles. Each major section connects to others in a deliberate sequence. Use the learning pathways below to move through material in an order that builds safely from foundations to complexity. You can also use the search function or browse by topic if you have a specific question — but if you are new, the structured pathway approach is strongly recommended over browsing at random.
All pages include a "Related Resources" section linking to adjacent topics. Where external sources are referenced, we indicate whether they are peer-reviewed, institutional, or community-sourced, so you can calibrate confidence accordingly.
Follow the pathway that fits your experience level and goals. Each track lists recommended sequence, time commitment, and what you will be able to do when you complete it.
For: People with no prior psilocybin experience or education. Time commitment: 4–8 hours of reading over a weekend.
The beginner pathway is sequenced deliberately. Safety content comes first because understanding risk is the prerequisite for everything else. Do not skip ahead to dosing or species topics before completing the safety modules — the order is intentional.
For: People who have completed beginner content or have prior harm-reduction knowledge. Time commitment: 8–20 hours.
For: People with intermediate knowledge who want to understand the science deeply. Time commitment: 20–50+ hours.
The past five years have seen a significant expansion of formal academic offerings in psychedelic studies. Below are the most established programs as of 2026.
CIIS (ciis.edu) offers the Certificate in Psychedelic-Assisted Therapies and Research, widely regarded as the most comprehensive non-degree professional program in the US. The curriculum covers neuropharmacology, clinical models, ethics, cultural and indigenous contexts, and supervised practicum hours. Designed for licensed clinicians (LCSW, LPC, MFT, MD, PhD). Duration: approximately 9 months. CEU credits available.
Naropa (naropa.edu) integrates psychedelic studies with contemplative and Buddhist-informed therapeutic frameworks. Programs include a Graduate Certificate in Psychedelic-Assisted Therapy and integration within their MA in Transpersonal Counseling Psychology. Particularly suited to practitioners interested in the spiritual and somatic dimensions alongside clinical competency.
The Berkeley Center for the Science of Psychedelics (BCSP) conducts neuroimaging research and offers public educational programming including lectures, interviews, and courses. Suitable for people without clinical backgrounds who want rigorous scientific education.
While Johns Hopkins does not offer public-facing courses, their Center (hopkinspsychedelic.org) publishes extensive research, and their team teaches through affiliated programs. The EMBARK model of psychedelic-assisted therapy — developed by NYU and Columbia researchers — has training workshops accessible to licensed clinicians.
Imperial's Centre for Psychedelic Research (imperial.ac.uk/psychedelic-research-centre) offers public lectures and has developed academic course material integrated into their clinical psychology programs. Best known for landmark neuroscience and comparative trial research.
Beyond CIIS and Naropa, several other programs offer professional certificates. Key considerations when evaluating any program:
Programs to research further include: Synthesis Institute, Fluence Psychedelic Education, Being True to You (integration coaching), and the Integrative Psychiatry Institute. Newer programs vary widely in quality — apply the evaluation criteria above rigorously.
The rapid growth of public interest in psychedelics has produced a corresponding growth in low-quality, sensationalized, and commercially motivated content. Applying basic critical evaluation protects you from misinformation.
People working in harm reduction contexts — festival medical teams, drug checking services, peer support workers, and crisis intervention providers — have specific educational needs that differ from general public education or clinical training.
Suggested sequences by goal: personal growth, research literacy, or clinical practice — with estimated hours and required reading for each.
Self-assessment templates, learning journals, and check-ins to measure progress and identify knowledge gaps before moving to advanced material.
Reminders on legal considerations, data privacy for research participation, scope-of-practice boundaries for professionals, and when education requires professional supervision.
If you are new, begin with the Beginner Courses and complete the safety modules first. Safety fundamentals — set and setting, dosing, drug interactions, contraindications, and emergency planning — provide the foundation for everything else. Skipping safety to reach interesting content faster is a common error that increases risk significantly.
Beginner tracks require no prerequisites. Advanced and professional tracks expect prior foundational knowledge. Professional programs (MAPS, CIIS) typically require existing mental health licensure. The Oregon and Colorado facilitator licensing pathways do not require prior mental health credentials but do require completing state-approved training programs. Always check specific program requirements before enrolling and paying fees.
Yes. CIIS offers a Certificate in Psychedelic-Assisted Therapies with CEU recognition. MAPS trains licensed clinicians in their MDMA-assisted therapy protocol. Oregon licenses Psilocybin Facilitators through a state-administered process. Always verify what a certificate qualifies you to do legally in your jurisdiction — credential recognition varies significantly and the field is evolving rapidly.
Beginner modules can be completed in a weekend. Intermediate tracks typically require 8–20 hours spread over several weeks. Advanced tracks are 20–50+ hours. Professional certification programs (CIIS, MAPS) span 6–12 months and include supervised practicum hours that extend total time commitment further. Oregon facilitator training requires 160 hours plus a practicum component.
Yes — combining modules is effective when you have specific knowledge gaps. However, always respect recommended sequencing: safety and foundations before advanced specialization. Jumping directly to dosing science or cultivation without completing harm-reduction fundamentals is the most common and most consequential sequencing error.
Apply four questions: (1) Does it cite peer-reviewed research? (2) Does it clearly distinguish established findings from speculation or anecdote? (3) Does it include contraindications and harm-reduction information alongside benefits? (4) Is funding and conflict of interest disclosed? Sources that report only positive effects without risks or legal context are not suitable as primary educational materials.
MAPS Zendo Project training is the most widely used formal program for psychedelic crisis support in non-clinical settings. DanceSafe provides drug checking and peer support training. The Fireside Project crisis line also offers training resources. TripSit's drug combination database is a practical rapid-reference tool. For integration-focused workers, Psychedelic Support (psychedelic.support) lists certified integration practitioners and offers professional resources.